VIRMA Gene

Name vir like m6A methyltransferase associated
Description Enables RNA binding activity. Involved in mRNA processing. Located in RNA N6-methyladenosine methyltransferase complex; cytosol; and nuclear speck. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nN6‐methyladenosine (m6A) is a widespread post‐transcriptional modification that regulates RNA fate, and VIRMA (also known as KIAA1429) represents the largest constituent of the m6A methyltransferase complex. Through its RNA binding domain, VIRMA orchestrates m6A deposition, influencing RNA splicing, processing, and stability. Aberrant expression of VIRMA has been documented in diverse pathological conditions including hepatocellular carcinoma, kidney cancers, lung adenocarcinoma, gastric malignancies, atherosclerosis, and germ cell tumors, highlighting its central role in modulating transcriptomic programs and supporting its potential as a biomarker in disease progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nDetailed mechanistic investigations have revealed that VIRMA exerts its oncogenic influence by modulating the stability and translation of key transcripts. For instance, in breast, gastric, and lung cancers, VIRMA has been shown to affect the m6A modification of mRNAs encoding regulators such as CDK1, LINC00958 and DAPK3, as well as to control transcript stability via both m6A‐dependent and independent mechanisms (e.g., HK2 and long noncoding RNA networks like LINC00667). In nasopharyngeal carcinoma, intrahepatic cholangiocarcinoma, ovarian cancer, and Ewing sarcoma, VIRMA‐guided modifications fine‐tune the expression of oncogenes and tumor suppressors (such as E2F7, PTGS2, and components of circRNA axes), establishing intricate regulatory loops that drive tumorigenesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "26"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond reprogramming RNA metabolism to favor tumorigenesis, VIRMA contributes to therapeutic resistance, cell death regulation, and metastatic progression. In lung adenocarcinoma and colorectal cancer, VIRMA‐mediated m6A modifications activate signaling cascades such as the JNK/MAPK pathway and mitigate ferroptotic cell death, thereby fostering radioresistance and chemoresistance. Moreover, its roles extend to head and neck and oral squamous cell carcinomas, as well as to hematologic malignancies like multiple myeloma, while emerging evidence also implicates VIRMA in developmental disorders including Hirschsprung’s disease. Collectively, these findings underscore VIRMA’s broad biological impact and validate its promise as a prognostic biomarker and therapeutic target across multiple clinical contexts."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "27", "end_ref": "36"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "João Lobo, Ana Laura Costa, Mariana Cantante, et al. "}, {"type": "b", "children": [{"type": "t", "text": "m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-019-1837-z"}], "href": "https://doi.org/10.1186/s12967-019-1837-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30866959"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30866959"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Tian Lan, Hui Li, Delin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-019-1106-z"}], "href": "https://doi.org/10.1186/s12943-019-1106-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31856849"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31856849"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Maoyu Wang, Yongliang Yang, Jing Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "A-YTHDF3-Zeb1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2020.118082"}], "href": "https://doi.org/10.1016/j.lfs.2020.118082"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32653519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32653519"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Zhuolun Sun, Changying Jing, Chutian Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.104053"}], "href": "https://doi.org/10.18632/aging.104053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33177247"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33177247"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Wenhua Zhao, Yuan Xie "}, {"type": "b", "children": [{"type": "t", "text": "KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2020.153284"}], "href": "https://doi.org/10.1016/j.prp.2020.153284"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33249400"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33249400"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Paramasivam Arumugam, Rinku George, Vijayashree Priyadharsini Jayaseelan "}, {"type": "b", "children": [{"type": "t", "text": "Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Oral Biol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.archoralbio.2020.105030"}], "href": "https://doi.org/10.1016/j.archoralbio.2020.105030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33383437"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33383437"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Rui Hu, Shan Chen, Jianxin Yan "}, {"type": "b", "children": [{"type": "t", "text": "Blocking circ-CNST suppresses malignant behaviors of osteosarcoma cells and inhibits glycolysis through circ-CNST-miR-578-LDHA/PDK1 ceRNA networks."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Orthop Surg Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13018-021-02427-0"}], "href": "https://doi.org/10.1186/s13018-021-02427-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33962616"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33962616"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Vera Miranda-Gonçalves, João Lobo, Catarina Guimarães-Teixeira, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The component of the m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-021-02072-9"}], "href": "https://doi.org/10.1186/s13046-021-02072-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34446080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34446080"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Chang Zhang, Qi Sun, Xu Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Commun (Lond) (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cac2.12325"}], "href": "https://doi.org/10.1002/cac2.12325"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35730068"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35730068"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Bingxi Tang, Mingdong Li, Yanbing Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "N[6]-methyladenosine (m[6]A) writer KIAA1429 accelerates gastric cancer oxaliplatin chemoresistance by targeting FOXM1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00432-022-04426-y"}], "href": "https://doi.org/10.1007/s00432-022-04426-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36326914"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36326914"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Ye Kuang, Yun Cheng, Jia Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KIAA1429 mediates epithelial mesenchymal transition in sorafenib-resistant hepatocellular carcinoma through m6A methylation modification."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.5432"}], "href": "https://doi.org/10.1002/cam4.5432"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36420693"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36420693"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Jian Rong, Yingxin Jie, Hui Zhao "}, {"type": "b", "children": [{"type": "t", "text": "m6A 'writer' KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biotechnol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12033-022-00614-w"}], "href": "https://doi.org/10.1007/s12033-022-00614-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36463391"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36463391"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Jia-Yi Qian, Jian Gao, Xi Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-019-0861-z"}], "href": "https://doi.org/10.1038/s41388-019-0861-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31285549"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31285549"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Desheng Yang, Shuang Chang, Fuchun Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " A transferase KIAA1429-stabilized LINC00958 accelerates gastric cancer aerobic glycolysis through targeting GLUT1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "IUBMB Life (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/iub.2545"}], "href": "https://doi.org/10.1002/iub.2545"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34409730"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34409730"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yongfang Xu, Yunhao Chen, Yinan Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VIRMA contributes to non-small cell lung cancer progression via N"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "-methyladenosine-dependent DAPK3 post-transcriptional modification."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2021.08.027"}], "href": "https://doi.org/10.1016/j.canlet.2021.08.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34520821"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34520821"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ying Li, Liang He, Yingkai Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "N"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2065952"}], "href": "https://doi.org/10.1080/21655979.2022.2065952"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35546050"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35546050"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Saiyu Ren, Yuxing Zhang, Xiaodong Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2077893"}], "href": "https://doi.org/10.1080/21655979.2022.2077893"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36700472"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36700472"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Zi-Qi Zheng, Zhuo-Hui Huang, Ye-Lin Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2023.104677"}], "href": "https://doi.org/10.1016/j.jbc.2023.104677"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37028765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37028765"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Chun-Peng Zhang, Xin-Ying Huang "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Cell (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13577-023-00933-3"}], "href": "https://doi.org/10.1007/s13577-023-00933-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37368192"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37368192"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Hongfa Xu, Xiaowen Lin, Zhongliang Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gastroenterol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00535-023-02015-5"}], "href": "https://doi.org/10.1007/s00535-023-02015-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37391589"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37391589"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Chao Ma, Qiming Zheng, Yepeng Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.204968"}], "href": "https://doi.org/10.18632/aging.204968"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37606975"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37606975"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Kezhe Tan, Wenjie Lu, Feng Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-023-02828-5"}], "href": "https://doi.org/10.1186/s13046-023-02828-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37759224"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37759224"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Lijuan Gan, Shengchao Zhao, Yang Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Direct (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13062-023-00420-7"}], "href": "https://doi.org/10.1186/s13062-023-00420-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37807062"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37807062"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Lingling Wu, Yuanhong Zhou, Jun Fu "}, {"type": "b", "children": [{"type": "t", "text": "KIAA1429 Promotes Nasopharyngeal Carcinoma Progression by Mediating m6A Modification of PTGS2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Crit Rev Immunol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1615/CritRevImmunol.2023050249"}], "href": "https://doi.org/10.1615/CritRevImmunol.2023050249"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37830191"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37830191"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Houhong Wang, Wenli Chen, Yayun Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KIAA1429 protects hepatocellular carcinoma cells from ferroptotic cell death with a m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " A-dependent posttranscriptional modification of SLC7A11."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.17997"}], "href": "https://doi.org/10.1111/jcmm.17997"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37830241"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37830241"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Meihua Shan, Dong Liu, Liangbo Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2023.216598"}], "href": "https://doi.org/10.1016/j.canlet.2023.216598"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38224863"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38224863"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Xi Lin, Rongyi Ye, Zhiming Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "A-dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Resist Updat (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.drup.2022.100908"}], "href": "https://doi.org/10.1016/j.drup.2022.100908"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36493511"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36493511"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Shurui Zhou, Kege Yang, Shaojie Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "A) modification."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-023-03897-y"}], "href": "https://doi.org/10.1186/s12967-023-03897-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36691046"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36691046"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Chunyu Zhu, Yameng Cheng, Yao Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "UBR5"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " mRNA and m6A levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomol Biomed (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.17305/bb.2024.10358"}], "href": "https://doi.org/10.17305/bb.2024.10358"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38577917"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38577917"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Xiaoqing Chen, Renxiu Fan "}, {"type": "b", "children": [{"type": "t", "text": "Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Oral Pathol Med (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jop.13531"}], "href": "https://doi.org/10.1111/jop.13531"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38531807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38531807"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Yang Yang, Mengzhen Zhang, Nan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hirschsprung's disease: m6A methylase VIRMA suppresses cell migration and proliferation by regulating GSK3β."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatr Res (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41390-024-03136-0"}], "href": "https://doi.org/10.1038/s41390-024-03136-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38658662"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38658662"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Wei Guo, Tan Wang, Qilin Huai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thorac Cancer (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1759-7714.15327"}], "href": "https://doi.org/10.1111/1759-7714.15327"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38717936"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38717936"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Hao Chen, Peipei Zhu, Dan Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role and mechanism of KIAA1429 in regulating cellular ferroptosis and radioresistance in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomol Biomed (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.17305/bb.2024.10313"}], "href": "https://doi.org/10.17305/bb.2024.10313"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38843497"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38843497"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Di Xu, Ziming Wang, Fajiu Li "}, {"type": "b", "children": [{"type": "t", "text": "KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Crit Rev Immunol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1615/CritRevImmunol.2024052728"}], "href": "https://doi.org/10.1615/CritRevImmunol.2024052728"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38848293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38848293"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Yue Wu, Yi Luo, Xingchen Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Toxicol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10565-024-09904-2"}], "href": "https://doi.org/10.1007/s10565-024-09904-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39060874"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39060874"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Junjun Huang, Jihua Guo, Rong Jia "}, {"type": "b", "children": [{"type": "t", "text": "N6-Methyladenosine Methyltransferase Component KIAA1429 Is a Potential Target of Cancer Therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomolecules (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/biom14101319"}], "href": "https://doi.org/10.3390/biom14101319"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39456252"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39456252"}]}]}]}
NCBI Gene ID 25962
API
Download Associations
Predicted Functions View VIRMA's ARCHS4 Predicted Functions.
Co-expressed Genes View VIRMA's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View VIRMA's ARCHS4 Predicted Functions.

Functional Associations

VIRMA has 1,920 functional associations with biological entities spanning 5 categories (functional term, phrase or reference, chemical, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 40 datasets.

Click the + buttons to view associations for VIRMA from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of VIRMA gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with VIRMA protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with VIRMA gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of VIRMA gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of VIRMA gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
CM4AI U2OS Cell Map Protein Localization Assemblies assemblies containing VIRMA protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing VIRMA protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with VIRMA protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of VIRMA protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with VIRMA gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with VIRMA gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with VIRMA gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with VIRMA gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
GlyGen Glycosylated Proteins ligands (chemical) binding VIRMA protein from the GlyGen Glycosylated Proteins dataset.
GO Biological Process Annotations 2023 biological processes involving VIRMA gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving VIRMA gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2023 cellular components containing VIRMA protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing VIRMA protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by VIRMA gene from the curated GO Molecular Function Annotations 2023 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of VIRMA gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of VIRMA gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with VIRMA gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by VIRMA gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of VIRMA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of VIRMA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by VIRMA gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of VIRMA gene from the NIBR DRUG-seq U2OS MoA Box dataset.
PFOCR Pathway Figure Associations 2023 pathways involving VIRMA protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving VIRMA protein from the Wikipathways PFOCR 2024 dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of VIRMA gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of VIRMA gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of VIRMA gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of VIRMA gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of VIRMA gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of VIRMA gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of VIRMA gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of VIRMA gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of VIRMA protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of VIRMA protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with VIRMA protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.